Author Information
Dimitrios P. Kontoyiannis is a prominent researcher in the field of infectious diseases, currently affiliated with the Department of Infectious Diseases at MD Anderson Cancer Center in Houston, Texas, USA. His work primarily focuses on fungal infections, immune response, and the implications of these in immunocompromised patients, particularly those with cancer.Research Contributions
Dimitrios P. Kontoyiannis has made significant contributions to the study of invasive fungal infections and their management, particularly in immunocompromised populations such as cancer patients. In 2022, his research explored various aspects of fungal infections including the PD-1/PD-L1 immune checkpoint pathway, both in the context of infections and immune checkpoint inhibitor therapies. His work also delves into non-invasive testing for fungal diseases, the clinical analysis of pulmonary mucormycosis, and the impact of environmental factors such as floodwater damage on mold infections. Furthermore, he has investigated the role of microbiome changes due to antibiotic exposure and the development of investigational antifungal agents.Aliases
Dimitrios P. Kontoyiannis is known by several aliases in academic publications, including D P Kontoyiannis, D Kontoyiannis, Dimitrios P Kontoyiannis, D.p. Kontoyiannis, Dimitrios p. Kontoyiannis, D. P. Kontoyiannis, and Dimitrios Kontoyiannis.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
50,941 |
| H-index |
113 |
| Paper Count |
770 |
